Cargando…

Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients

BACKGROUND: Helicobacter pylori infection and subsequent gastric inflammation have been proposed as risk factors for the development of insulin resistance and cardiovascular disease. In this study we assessed the possible association of H. pylori bacterial load, and serum biomarker of gastric inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahadoran, Zahra, Mirmiran, Parvin, Zarif-yeaganeh, Maryam, Zojaji, Homayoun, Azizi, Fereidoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595352/
https://www.ncbi.nlm.nih.gov/pubmed/26435133
http://dx.doi.org/10.3803/EnM.2015.30.3.280
_version_ 1782393592624447488
author Bahadoran, Zahra
Mirmiran, Parvin
Zarif-yeaganeh, Maryam
Zojaji, Homayoun
Azizi, Fereidoun
author_facet Bahadoran, Zahra
Mirmiran, Parvin
Zarif-yeaganeh, Maryam
Zojaji, Homayoun
Azizi, Fereidoun
author_sort Bahadoran, Zahra
collection PubMed
description BACKGROUND: Helicobacter pylori infection and subsequent gastric inflammation have been proposed as risk factors for the development of insulin resistance and cardiovascular disease. In this study we assessed the possible association of H. pylori bacterial load, and serum biomarker of gastric inflammation with cardiometabolic risk factors in diabetic patients. METHODS: In this cross-sectional study, 84 H. pylori-infected type 2 diabetic patients were assessed for anthropometrics, biochemical and clinical measurements. Pearson correlation test, linear, and logarithmic regression curve estimation models were used to assess the association of H. pylori stool antigen (HpSAg) levels, and pepsinogen I (PGI) to pepsinogen II (PGII) ratio with fasting serum glucose, insulin, serum lipid and lipoprotein parameters, malondialdehyde, high-sensitive C-reactive protein (hs-CRP), systolic and diastolic blood pressure, body weight, waist circumference and lipid accumulation product (LAP) index. RESULTS: The mean age of participants was 54±10 years, and 44% were men. Mean HpSAg levels and PGI/PGII ratio were 0.24±0.23 µg/mL and 9.9±9.0, respectively. Higher HpSAg as well as lower PGI/PGII was correlated with higher anthropometric measures and LAP. A significant negative correlation between PGI/PGII ratio and blood pressure (r=-0.21 and r=-0.22, systolic and diastolic, respectively, P<0.05), serum insulin (r=-0.17, P=0.05), and hs-CRP (r=-0.17, P=0.05) was observed. A significant linear association between PGI/PGII ratio with serum triglycerides (β=-0.24, P<0.05), serum high density lipoprotein cholesterol (HDL-C; β=0.43, P<0.01), and triglycerides/HDL-C ratio (β=-0.28, P<0.05) were observed. CONCLUSION: Higher H. pylori bacterial load and lower PGI/PGII ratio was associated with higher levels of cardiometabolic risk factors in H. pylori infected type 2 diabetic patients.
format Online
Article
Text
id pubmed-4595352
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Korean Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-45953522015-10-13 Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients Bahadoran, Zahra Mirmiran, Parvin Zarif-yeaganeh, Maryam Zojaji, Homayoun Azizi, Fereidoun Endocrinol Metab (Seoul) Original Article BACKGROUND: Helicobacter pylori infection and subsequent gastric inflammation have been proposed as risk factors for the development of insulin resistance and cardiovascular disease. In this study we assessed the possible association of H. pylori bacterial load, and serum biomarker of gastric inflammation with cardiometabolic risk factors in diabetic patients. METHODS: In this cross-sectional study, 84 H. pylori-infected type 2 diabetic patients were assessed for anthropometrics, biochemical and clinical measurements. Pearson correlation test, linear, and logarithmic regression curve estimation models were used to assess the association of H. pylori stool antigen (HpSAg) levels, and pepsinogen I (PGI) to pepsinogen II (PGII) ratio with fasting serum glucose, insulin, serum lipid and lipoprotein parameters, malondialdehyde, high-sensitive C-reactive protein (hs-CRP), systolic and diastolic blood pressure, body weight, waist circumference and lipid accumulation product (LAP) index. RESULTS: The mean age of participants was 54±10 years, and 44% were men. Mean HpSAg levels and PGI/PGII ratio were 0.24±0.23 µg/mL and 9.9±9.0, respectively. Higher HpSAg as well as lower PGI/PGII was correlated with higher anthropometric measures and LAP. A significant negative correlation between PGI/PGII ratio and blood pressure (r=-0.21 and r=-0.22, systolic and diastolic, respectively, P<0.05), serum insulin (r=-0.17, P=0.05), and hs-CRP (r=-0.17, P=0.05) was observed. A significant linear association between PGI/PGII ratio with serum triglycerides (β=-0.24, P<0.05), serum high density lipoprotein cholesterol (HDL-C; β=0.43, P<0.01), and triglycerides/HDL-C ratio (β=-0.28, P<0.05) were observed. CONCLUSION: Higher H. pylori bacterial load and lower PGI/PGII ratio was associated with higher levels of cardiometabolic risk factors in H. pylori infected type 2 diabetic patients. Korean Endocrine Society 2015-09 2015-05-18 /pmc/articles/PMC4595352/ /pubmed/26435133 http://dx.doi.org/10.3803/EnM.2015.30.3.280 Text en Copyright © 2015 Korean Endocrine Society http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Bahadoran, Zahra
Mirmiran, Parvin
Zarif-yeaganeh, Maryam
Zojaji, Homayoun
Azizi, Fereidoun
Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients
title Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients
title_full Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients
title_fullStr Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients
title_full_unstemmed Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients
title_short Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients
title_sort helicobacter pylori stool antigen levels and serological biomarkers of gastric inflammation are associated with cardio-metabolic risk factors in type 2 diabetic patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595352/
https://www.ncbi.nlm.nih.gov/pubmed/26435133
http://dx.doi.org/10.3803/EnM.2015.30.3.280
work_keys_str_mv AT bahadoranzahra helicobacterpyloristoolantigenlevelsandserologicalbiomarkersofgastricinflammationareassociatedwithcardiometabolicriskfactorsintype2diabeticpatients
AT mirmiranparvin helicobacterpyloristoolantigenlevelsandserologicalbiomarkersofgastricinflammationareassociatedwithcardiometabolicriskfactorsintype2diabeticpatients
AT zarifyeaganehmaryam helicobacterpyloristoolantigenlevelsandserologicalbiomarkersofgastricinflammationareassociatedwithcardiometabolicriskfactorsintype2diabeticpatients
AT zojajihomayoun helicobacterpyloristoolantigenlevelsandserologicalbiomarkersofgastricinflammationareassociatedwithcardiometabolicriskfactorsintype2diabeticpatients
AT azizifereidoun helicobacterpyloristoolantigenlevelsandserologicalbiomarkersofgastricinflammationareassociatedwithcardiometabolicriskfactorsintype2diabeticpatients